Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1993-4-30
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0167-8140
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
180-2
|
pubmed:dateRevised |
2005-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8465021-Brain Neoplasms,
pubmed-meshheading:8465021-Cisplatin,
pubmed-meshheading:8465021-Combined Modality Therapy,
pubmed-meshheading:8465021-Female,
pubmed-meshheading:8465021-Humans,
pubmed-meshheading:8465021-Lung Neoplasms,
pubmed-meshheading:8465021-Radiosurgery,
pubmed-meshheading:8465021-Tumor Cells, Cultured,
pubmed-meshheading:8465021-Uterine Cervical Neoplasms
|
pubmed:year |
1993
|
pubmed:articleTitle |
Combined modality therapy in high dose radioneurosurgery.
|
pubmed:publicationType |
Letter,
Comment
|